New combo diabetes pill tested in healthy volunteers
NCT ID NCT07519265
First seen Apr 11, 2026 · Last updated Jun 21, 2026 · Updated 13 times
Summary
This study tests whether a new single pill that combines two diabetes drugs (chiglitazar and metformin) works the same as taking them separately. It involves 64 healthy adults who will take both versions and have their blood levels measured. The goal is to see if the combo pill is a safe and effective alternative for people with type 2 diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T2DM (TYPE 2 DIABETES MELLITUS) are added.
Genom att skicka in godkänner du våra Användarvillkor
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Chiglitazar and metformin extended-release fixed-dose combination tablet
What this could lead to
If successful, this could lead to a simpler, single-pill option for people with type 2 diabetes, making it easier to take their medication.
What could go wrong
This is an early-stage study in healthy people, not those with diabetes. It only checks if the combo pill is absorbed similarly, not if it works better or has fewer side effects.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.